Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt

Keyphrases

• Refractory Ascites 100%
• Treatment Results 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Mid-term Outcome 100%
• Ascites 66%
• Renal Failure 33%
• Treatment Failure 33%
• Liver Failure 33%
• Ultrasound 16%
• Medical Therapy 16%
• 1-year Follow-up 16%
• Non-associated 16%
• Early Mortality 16%
• Creatinine Level 16%
• Encephalopathy 16%
• Major Complications 16%
• Lost to Follow-up 16%
• Overall Mortality 16%
• Paracentesis 16%
• Shunt Procedure 16%
• 3-month Mortality 16%
• Intraperitoneal Hemorrhage 16%
• Hastening Death 16%
• Successful Treatment 16%
• Bilirubin Level 16%

Medicine and Dentistry

• Ascites 100%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Shunt Creation 42%
• Renal Failure 28%
• Liver Failure 28%
• Combination Therapy 14%
• Creatinine 14%
• Brain Disease 14%
• Bilirubin 14%
• Paracentesis 14%
• Hemoperitoneum 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Ascites 100%
• Kidney Failure 28%
• Liver Failure 28%
• Brain Disease 14%
• Creatinine 14%
• Bilirubin 14%
• Combination Therapy 14%
• Hemoperitoneum 14%